ArticleOncotarget2014

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.

Kathleen A Wilson-Edell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.